Infosys Limited (NYSE:INFY) Shares Sold by Boston Common Asset Management LLC

Boston Common Asset Management LLC decreased its stake in shares of Infosys Limited (NYSE:INFY) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 435,349 shares of the technology company’s stock after selling 3,590 shares during the period. Boston Common Asset Management LLC’s holdings in Infosys were worth $9,543,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Mizuho Securities Co. Ltd. acquired a new position in shares of Infosys in the 3rd quarter worth approximately $33,000. Wilmington Savings Fund Society FSB acquired a new position in shares of Infosys in the 3rd quarter worth approximately $57,000. Whittier Trust Co. of Nevada Inc. grew its stake in shares of Infosys by 25.3% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 3,795 shares of the technology company’s stock worth $85,000 after purchasing an additional 766 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Infosys by 34.3% in the 3rd quarter. GAMMA Investing LLC now owns 3,936 shares of the technology company’s stock worth $88,000 after purchasing an additional 1,005 shares during the last quarter. Finally, Advisor Resource Council acquired a new position in shares of Infosys in the 3rd quarter worth approximately $202,000. Institutional investors and hedge funds own 16.20% of the company’s stock.

Infosys Stock Performance

INFY stock opened at $21.16 on Friday. The stock has a market cap of $87.65 billion, a P/E ratio of 27.13, a P/E/G ratio of 3.71 and a beta of 1.00. The firm has a 50 day simple moving average of $22.54 and a 200 day simple moving average of $22.15. Infosys Limited has a 52 week low of $16.04 and a 52 week high of $23.63.

Infosys (NYSE:INFY) last posted its quarterly earnings results on Thursday, January 16th. The technology company reported $0.19 EPS for the quarter, hitting the consensus estimate of $0.19. Infosys had a net margin of 17.15% and a return on equity of 31.43%. During the same quarter in the previous year, the company earned $0.18 earnings per share. Sell-side analysts predict that Infosys Limited will post 0.74 EPS for the current year.

Infosys Increases Dividend

The firm also recently announced a semi-annual dividend, which was paid on Tuesday, October 29th. Shareholders of record on Friday, January 1st were paid a $0.2126 dividend. The ex-dividend date of this dividend was Tuesday, October 29th. This is a boost from Infosys’s previous semi-annual dividend of $0.20. This represents a yield of 1.1%. Infosys’s payout ratio is 53.85%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on INFY shares. Guggenheim reaffirmed a “neutral” rating on shares of Infosys in a research note on Friday. Hsbc Global Res raised shares of Infosys from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 9th. HSBC raised shares of Infosys from a “hold” rating to a “buy” rating in a research note on Monday, December 9th. StockNews.com cut shares of Infosys from a “buy” rating to a “hold” rating in a report on Friday, January 3rd. Finally, BMO Capital Markets raised their target price on shares of Infosys from $23.00 to $25.00 and gave the stock a “market perform” rating in a report on Friday, October 18th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Infosys has a consensus rating of “Hold” and an average price target of $20.22.

Infosys Company Profile

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.